Oncogenic mutations in histologically normal endometrium: the new normal?

The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of pathology Jg. 249; H. 2; S. 173 - 181
Hauptverfasser:	Lac, Vivian, Nazeran, Tayyebeh M, Tessier‐Cloutier, Basile, Aguirre‐Hernandez, Rosalia, Albert, Arianne, Lum, Amy, Khattra, Jaswinder, Praetorius, Teresa, Mason, Madeline, Chiu, Derek, Köbel, Martin, Yong, Paul J, Gilks, Blake C, Anglesio, Michael S, Huntsman, David G
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Chichester, UK John Wiley & Sons, Ltd 01.10.2019 Wiley Subscription Services, Inc
Schlagworte:	Adult Age Factors Aging Aging - genetics Aging - metabolism digital PCR DNA Mutational Analysis Early Detection of Cancer - methods Endometrial Neoplasms - genetics Endometrial Neoplasms - metabolism Endometrial Neoplasms - pathology Endometriosis Endometrium Endometrium - metabolism Epithelium Esophagus Female Fibroblast growth factor receptor 2 Gynecological cancer Healthy Volunteers Humans Hyperplasia Immunohistochemistry Malignancy Middle Aged Mutation Mutation hot spots Mutation Rate Next-generation sequencing normal tissue Oncogenes Paraffin Peritoneum Predictive Value of Tests PTEN protein Reproducibility of Results Skin somatic mutations Uterus Young Adult somatic mutations endometrium normal tissue aging digital PCR
ISSN:	0022-3417, 1096-9896, 1096-9896
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have described somatic driver mutations in normal skin, blood, peritoneal washings, and esophageal epithelium. Such findings prompt speculation on whether such mutations exist in other tissues, such as the eutopic endometrium in particular, due to the highly regenerative nature of the endometrium and the recent observation of recurrent somatic driver mutations in deep infiltrating and iatrogenic endometriosis (tissues believed to be derived from the eutopic endometrium) by our group and others. In the current study we investigated the presence of somatic driver mutations in histologically normal endometrium from women lacking evidence of gynecologic malignancy or endometrial hyperplasia. Twenty‐five women who underwent hysterectomies and 85 women who underwent endometrial biopsies were included in this study. Formalin‐fixed, paraffin‐embedded tissue specimens were analyzed by means of targeted sequencing followed by orthogonal validation with droplet digital PCR. PTEN and ARID1A immunohistochemistry (IHC) was also performed as surrogates for inactivating mutations in the respective genes. Overall, we observed somatic driver‐like events in over 50% of normal endometrial samples analyzed, including hotspot mutations in KRAS, PIK3CA, and FGFR2 as well as PTEN‐loss by IHC. Analysis of anterior and posterior samplings collected from women who underwent hysterectomies was consistent with the presence of somatic driver mutations within clonal pockets spread throughout the uterus. The prevalence of such oncogenic mutations also increased with age (OR: 1.05 [95% CI: 1.00–1.10], p = 0.035). These findings have implications on our understanding of aging and so‐called ‘normal tissues’, thereby necessitating caution in the utilization of mutation‐based early detection tools for endometrial or other cancers. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
AbstractList	The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have described somatic driver mutations in normal skin, blood, peritoneal washings, and esophageal epithelium. Such findings prompt speculation on whether such mutations exist in other tissues, such as the eutopic endometrium in particular, due to the highly regenerative nature of the endometrium and the recent observation of recurrent somatic driver mutations in deep infiltrating and iatrogenic endometriosis (tissues believed to be derived from the eutopic endometrium) by our group and others. In the current study we investigated the presence of somatic driver mutations in histologically normal endometrium from women lacking evidence of gynecologic malignancy or endometrial hyperplasia. Twenty-five women who underwent hysterectomies and 85 women who underwent endometrial biopsies were included in this study. Formalin-fixed, paraffin-embedded tissue specimens were analyzed by means of targeted sequencing followed by orthogonal validation with droplet digital PCR. PTEN and ARID1A immunohistochemistry (IHC) was also performed as surrogates for inactivating mutations in the respective genes. Overall, we observed somatic driver-like events in over 50% of normal endometrial samples analyzed, including hotspot mutations in KRAS, PIK3CA, and FGFR2 as well as PTEN-loss by IHC. Analysis of anterior and posterior samplings collected from women who underwent hysterectomies was consistent with the presence of somatic driver mutations within clonal pockets spread throughout the uterus. The prevalence of such oncogenic mutations also increased with age (OR: 1.05 [95% CI: 1.00-1.10], p = 0.035). These findings have implications on our understanding of aging and so-called 'normal tissues', thereby necessitating caution in the utilization of mutation-based early detection tools for endometrial or other cancers. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have described somatic driver mutations in normal skin, blood, peritoneal washings, and esophageal epithelium. Such findings prompt speculation on whether such mutations exist in other tissues, such as the eutopic endometrium in particular, due to the highly regenerative nature of the endometrium and the recent observation of recurrent somatic driver mutations in deep infiltrating and iatrogenic endometriosis (tissues believed to be derived from the eutopic endometrium) by our group and others. In the current study we investigated the presence of somatic driver mutations in histologically normal endometrium from women lacking evidence of gynecologic malignancy or endometrial hyperplasia. Twenty-five women who underwent hysterectomies and 85 women who underwent endometrial biopsies were included in this study. Formalin-fixed, paraffin-embedded tissue specimens were analyzed by means of targeted sequencing followed by orthogonal validation with droplet digital PCR. PTEN and ARID1A immunohistochemistry (IHC) was also performed as surrogates for inactivating mutations in the respective genes. Overall, we observed somatic driver-like events in over 50% of normal endometrial samples analyzed, including hotspot mutations in KRAS, PIK3CA, and FGFR2 as well as PTEN-loss by IHC. Analysis of anterior and posterior samplings collected from women who underwent hysterectomies was consistent with the presence of somatic driver mutations within clonal pockets spread throughout the uterus. The prevalence of such oncogenic mutations also increased with age (OR: 1.05 [95% CI: 1.00-1.10], p = 0.035). These findings have implications on our understanding of aging and so-called 'normal tissues', thereby necessitating caution in the utilization of mutation-based early detection tools for endometrial or other cancers. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have described somatic driver mutations in normal skin, blood, peritoneal washings, and esophageal epithelium. Such findings prompt speculation on whether such mutations exist in other tissues, such as the eutopic endometrium in particular, due to the highly regenerative nature of the endometrium and the recent observation of recurrent somatic driver mutations in deep infiltrating and iatrogenic endometriosis (tissues believed to be derived from the eutopic endometrium) by our group and others. In the current study we investigated the presence of somatic driver mutations in histologically normal endometrium from women lacking evidence of gynecologic malignancy or endometrial hyperplasia. Twenty-five women who underwent hysterectomies and 85 women who underwent endometrial biopsies were included in this study. Formalin-fixed, paraffin-embedded tissue specimens were analyzed by means of targeted sequencing followed by orthogonal validation with droplet digital PCR. PTEN and ARID1A immunohistochemistry (IHC) was also performed as surrogates for inactivating mutations in the respective genes. Overall, we observed somatic driver-like events in over 50% of normal endometrial samples analyzed, including hotspot mutations in KRAS, PIK3CA, and FGFR2 as well as PTEN-loss by IHC. Analysis of anterior and posterior samplings collected from women who underwent hysterectomies was consistent with the presence of somatic driver mutations within clonal pockets spread throughout the uterus. The prevalence of such oncogenic mutations also increased with age (OR: 1.05 [95% CI: 1.00-1.10], p = 0.035). These findings have implications on our understanding of aging and so-called 'normal tissues', thereby necessitating caution in the utilization of mutation-based early detection tools for endometrial or other cancers. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Author	Mason, Madeline Tessier‐Cloutier, Basile Köbel, Martin Aguirre‐Hernandez, Rosalia Khattra, Jaswinder Gilks, Blake C Praetorius, Teresa Chiu, Derek Albert, Arianne Huntsman, David G Yong, Paul J Lum, Amy Lac, Vivian Nazeran, Tayyebeh M Anglesio, Michael S
Author_xml	– sequence: 1 givenname: Vivian orcidid: 0000-0002-5303-6854 surname: Lac fullname: Lac, Vivian organization: BC Cancer Research Centre – sequence: 2 givenname: Tayyebeh M surname: Nazeran fullname: Nazeran, Tayyebeh M organization: Vancouver General Hospital – sequence: 3 givenname: Basile orcidid: 0000-0001-8739-3879 surname: Tessier‐Cloutier fullname: Tessier‐Cloutier, Basile organization: University of British Columbia – sequence: 4 givenname: Rosalia surname: Aguirre‐Hernandez fullname: Aguirre‐Hernandez, Rosalia organization: Contextual Genomics Inc – sequence: 5 givenname: Arianne surname: Albert fullname: Albert, Arianne organization: Women's Health Research Institute, British Columbia Women's Hospital – sequence: 6 givenname: Amy surname: Lum fullname: Lum, Amy organization: BC Cancer Research Centre – sequence: 7 givenname: Jaswinder surname: Khattra fullname: Khattra, Jaswinder organization: Contextual Genomics Inc – sequence: 8 givenname: Teresa surname: Praetorius fullname: Praetorius, Teresa organization: Tuebingen University Hospital – sequence: 9 givenname: Madeline surname: Mason fullname: Mason, Madeline organization: BC Cancer Research Centre – sequence: 10 givenname: Derek surname: Chiu fullname: Chiu, Derek organization: BC Cancer Research Centre – sequence: 11 givenname: Martin orcidid: 0000-0002-6615-2037 surname: Köbel fullname: Köbel, Martin organization: University of Calgary – sequence: 12 givenname: Paul J surname: Yong fullname: Yong, Paul J organization: BC Women's Hospital and Health Centre, Women' Health Centre – sequence: 13 givenname: Blake C surname: Gilks fullname: Gilks, Blake C organization: University of British Columbia – sequence: 14 givenname: Michael S orcidid: 0000-0003-1639-5003 surname: Anglesio fullname: Anglesio, Michael S email: m.anglesio@ubc.ca organization: University of British Columbia – sequence: 15 givenname: David G surname: Huntsman fullname: Huntsman, David G email: dhuntsma@bccancer.bc.ca organization: University of British Columbia
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/31187483$$D View this record in MEDLINE/PubMed
BookMark	eNp90U9LwzAYBvAgim7Tg19ACl700Jk0aZp4kTH8BwM9zHNJ08RF0mQmLWPf3s5NDwM95fD83pfwPkNw6LxTAJwjOEYQZjdL0S7GOUbkAAwQ5DTljNNDMOizLMUEFSdgGOMHhJDzPD8GJxghVhCGB-D5xUn_rpyRSdO1ojXexcS4ZGFi661_N1JYu06cD42wiXK1b1QbTNfcJu1CJU6tdtndKTjSwkZ1tntH4O3hfj59Smcvj8_TySyVBHGSYigYKnSOmIBY4VrWWuGqqisJa5hBIQUXuk9orTUrKqRJUbEccs0IYRLleASutnuXwX92KrZlY6JU1gqnfBfLLKOIU0oR6-nlHv3wXXD973rFKWeMYNyri53qqkbV5TKYRoR1-XOkHlxvgQw-xqD0L0Gw3BRQbgooNwX09mbPSrM9axuEsf9NrIxV679Xl6-T-dP3xBe9qZdc
CitedBy_id	crossref_primary_10_3390_biom13081253 crossref_primary_10_1002_path_5608 crossref_primary_10_1038_s41419_020_2559_0 crossref_primary_10_1158_2159_8290_CD_22_0145 crossref_primary_10_1186_s12958_022_01030_0 crossref_primary_10_1097_PAS_0000000000001963 crossref_primary_10_1111_jop_13394 crossref_primary_10_1016_j_ajog_2024_08_042 crossref_primary_10_1093_humrep_deaa255 crossref_primary_10_3390_jpm12071074 crossref_primary_10_1002_ijc_70074 crossref_primary_10_1158_2159_8290_CD_21_0245 crossref_primary_10_1038_s41588_021_00930_y crossref_primary_10_1038_s41467_021_26615_y crossref_primary_10_3390_cancers14020416 crossref_primary_10_1016_j_ygyno_2021_08_008 crossref_primary_10_1038_s41467_019_13708_y crossref_primary_10_1038_s12276_023_01140_8 crossref_primary_10_1111_cas_14507 crossref_primary_10_1038_s41379_020_00721_6 crossref_primary_10_1002_aac2_12061 crossref_primary_10_1111_cas_14871 crossref_primary_10_3390_cancers14092242 crossref_primary_10_1038_s41388_023_02802_7 crossref_primary_10_1002_path_5628 crossref_primary_10_3390_cancers15010111 crossref_primary_10_1007_s00018_021_03931_6 crossref_primary_10_1002_path_6433 crossref_primary_10_1016_j_mrrev_2024_108514 crossref_primary_10_2147_IJGM_S417430 crossref_primary_10_1016_j_fertnstert_2022_05_030 crossref_primary_10_17116_repro202430051101 crossref_primary_10_3390_cancers13246339 crossref_primary_10_1038_s41598_022_14240_8 crossref_primary_10_1038_s41588_025_02308_w crossref_primary_10_1146_annurev_pathmechdis_012418_012917 crossref_primary_10_1093_humrep_dez253 crossref_primary_10_1093_molehr_gaaf021 crossref_primary_10_3390_ph18060813 crossref_primary_10_1016_j_ygyno_2024_02_027 crossref_primary_10_1158_0008_5472_CAN_23_1362 crossref_primary_10_3390_ijms26093979 crossref_primary_10_1002_cjp2_317 crossref_primary_10_1002_path_5511 crossref_primary_10_1002_rmb2_12442 crossref_primary_10_1016_j_cell_2021_04_041 crossref_primary_10_1016_j_annonc_2022_09_156 crossref_primary_10_1093_humupd_dmz047 crossref_primary_10_1111_jop_13048 crossref_primary_10_1134_S0006297922110104 crossref_primary_10_3390_jpm12091519 crossref_primary_10_1097_PGP_0000000000000763 crossref_primary_10_1111_his_14227 crossref_primary_10_3390_jcm13071933 crossref_primary_10_1097_PGP_0000000000000889 crossref_primary_10_1016_j_ccell_2020_11_002 crossref_primary_10_1111_cas_15767 crossref_primary_10_1038_s41379_021_00861_3 crossref_primary_10_3390_biom13020336 crossref_primary_10_1016_j_mrrev_2022_108412 crossref_primary_10_1038_s41417_022_00547_1 crossref_primary_10_1002_path_5365 crossref_primary_10_3390_biomedicines12061276 crossref_primary_10_1007_s00109_020_02028_0 crossref_primary_10_1007_s43032_025_01910_x crossref_primary_10_2147_IJWH_S306135 crossref_primary_10_1016_j_path_2022_02_005 crossref_primary_10_1111_jog_15549 crossref_primary_10_1007_s43032_020_00451_9 crossref_primary_10_3390_life14060704 crossref_primary_10_1093_intimm_dxaa006 crossref_primary_10_1002_path_5778 crossref_primary_10_1038_s41586_020_2214_z crossref_primary_10_1002_hlca_202200132 crossref_primary_10_1097_PAI_0000000000001102 crossref_primary_10_1210_endrev_bnad020 crossref_primary_10_1093_humrep_deae269 crossref_primary_10_1016_j_mrrev_2025_108552 crossref_primary_10_3389_froh_2021_740788 crossref_primary_10_1056_NEJMra1810764 crossref_primary_10_1111_jog_16089 crossref_primary_10_1096_fj_202002178R crossref_primary_10_3390_diseases9010014 crossref_primary_10_1007_s00428_022_03367_8 crossref_primary_10_1038_s41379_022_01124_5 crossref_primary_10_3390_cancers12061676 crossref_primary_10_1093_jnen_nlaa004 crossref_primary_10_1007_s43032_022_00974_3 crossref_primary_10_1016_j_bpobgyn_2020_05_009 crossref_primary_10_1038_s41467_022_28568_2 crossref_primary_10_1093_humupd_dmaa045 crossref_primary_10_1038_s41392_024_01848_7 crossref_primary_10_1016_j_banm_2022_12_002 crossref_primary_10_1038_s10038_021_00940_y crossref_primary_10_1002_dc_24903 crossref_primary_10_1038_s41523_023_00607_1 crossref_primary_10_1002_ijc_34406 crossref_primary_10_3390_jpm11080713 crossref_primary_10_1111_cas_14571 crossref_primary_10_3389_froh_2021_677731 crossref_primary_10_1016_j_ygyno_2021_02_007 crossref_primary_10_3390_cancers13061439 crossref_primary_10_1007_s12672_025_03021_0 crossref_primary_10_1111_odi_13241 crossref_primary_10_1007_s00109_022_02239_7
Cites_doi	10.1073/pnas.1601311113 10.1038/nrendo.2013.255 10.1016/j.celrep.2018.07.037 10.1158/0008-5472.CAN-10-0149 10.1038/nature05610 10.1002/cjp2.103 10.1126/science.aab4082 10.20892/j.issn.2095-3941.2016.0004 10.3109/02770906709104321 10.1038/nature07943 10.1371/journal.pgen.1007108 10.1002/path.4516 10.1002/path.5136 10.1016/S0002-9378(25)90949-0 10.3390/ijms14035367 10.1002/cjp2.108 10.1038/ng.2270 10.1158/1078-0432.CCR-06-1375 10.1126/scitranslmed.aap8793 10.1093/humrep/dey332 10.1309/7JX6-B9U9-3P0R-EQNY 10.1016/j.cell.2011.02.013 10.1002/cncr.24218 10.1056/NEJMcp1000274 10.1056/NEJMoa1614814 10.1056/NEJMoa1008433 10.1101/505685 10.1158/0008-5472.CAN-14-0108 10.1093/nar/gkw1121 10.1016/S0092-8674(00)81683-9 10.1126/science.aaa6806 10.1126/science.aau3879 10.1371/journal.pone.0010387 10.1038/nature12113 10.1056/NEJMoa1709449
ContentType	Journal Article
Copyright	2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2019 Pathological Society of Great Britain and Ireland
Copyright_xml	– notice: 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. – notice: Copyright © 2019 Pathological Society of Great Britain and Ireland
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8
DOI	10.1002/path.5314
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic
DatabaseTitleList	MEDLINE CrossRef Genetics Abstracts MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1096-9896
EndPage	181
ExternalDocumentID	31187483 10_1002_path_5314 PATH5314
Genre	shortCommunication Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: BC Cancer Foundation funderid: Janet D. Cottrelle Foundation grant – fundername: Canadian Institutes of Health Research funderid: #154290 – fundername: Janet D. Cottrelle Foundation – fundername: Michael Smith Foundation for Health Research Health Professional‐Investigator Award – fundername: Canadian Cancer Society Research Institute funderid: #701603 – fundername: VGH & UBC Hospital Foundation
GroupedDBID	--- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1KJ 1L6 1OB 1OC 1ZS 29L 31~ 33P 3O- 3SF 3UE 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GSXLS H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M68 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 V2E VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XPP XV2 YQI YQJ ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM VXZ 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8
ID	FETCH-LOGICAL-c4194-30a817f518a03e3dcdfe3bbdbc0d020aca9af03e6dff87b1f47b8509f8448c153
IEDL.DBID	DRFUL
ISICitedReferencesCount	113
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000478363700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0022-3417 1096-9896
IngestDate	Fri Jul 11 13:09:57 EDT 2025 Sat Nov 29 14:32:03 EST 2025 Wed Feb 19 02:30:43 EST 2025 Sat Nov 29 07:03:42 EST 2025 Tue Nov 18 21:36:28 EST 2025 Wed Jan 22 16:38:21 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	somatic mutations endometrium normal tissue aging digital PCR
Language	English
License	2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4194-30a817f518a03e3dcdfe3bbdbc0d020aca9af03e6dff87b1f47b8509f8448c153
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0001-8739-3879 0000-0003-1639-5003 0000-0002-6615-2037 0000-0002-5303-6854
PMID	31187483
PQID	2296988433
PQPubID	1006392
PageCount	9
ParticipantIDs	proquest_miscellaneous_2261966618 proquest_journals_2296988433 pubmed_primary_31187483 crossref_primary_10_1002_path_5314 crossref_citationtrail_10_1002_path_5314 wiley_primary_10_1002_path_5314_PATH5314
PublicationCentury	2000
PublicationDate	October 2019
PublicationDateYYYYMMDD	2019-10-01
PublicationDate_xml	– month: 10 year: 2019 text: October 2019
PublicationDecade	2010
PublicationPlace	Chichester, UK
PublicationPlace_xml	– name: Chichester, UK – name: England – name: Bognor Regis
PublicationTitle	The Journal of pathology
PublicationTitleAlternate	J Pathol
PublicationYear	2019
Publisher	John Wiley & Sons, Ltd Wiley Subscription Services, Inc
Publisher_xml	– name: John Wiley & Sons, Ltd – name: Wiley Subscription Services, Inc
References	2018; 362 2012; 2012 2007; 446 2006; 12 2019; 34 2017; 45 2018; 246 2010; 363 2010; 362 2015; 349 2015; 348 2017; 376 2016; 13 2009; 115 2009; 458 2018; 24 2013; 14 1925; 9 2018; 4 2015; 236 1993; 53 2018; 378 1967; 5 2016; 113 2013; 497 2018 2000; 60 2000; 100 2014; 74 2010; 70 2010; 5 2018; 10 2012; 44 2001; 115 2011; 144 2018; 14 2014; 10 e_1_2_7_6_1 e_1_2_7_5_1 O'Hara AJ (e_1_2_7_28_1) 2012; 2012 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_29_1 Sasaki H (e_1_2_7_13_1) 1993; 53 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_22_1 Sato N (e_1_2_7_33_1) 2000; 60 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1
References_xml	– volume: 10 start-page: eaap8793 year: 2018 article-title: Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers publication-title: Sci Transl Med – volume: 45 start-page: D783 year: 2017 article-title: COSMIC: somatic cancer genetics at high‐resolution publication-title: Nucleic Acids Res – volume: 115 start-page: 32 year: 2001 end-page: 38 article-title: Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia publication-title: Am J Clin Pathol – volume: 113 start-page: 6005 year: 2016 end-page: 6010 article-title: Ultra‐deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues publication-title: Proc Natl Acad Sci U S A – volume: 144 start-page: 646 year: 2011 end-page: 674 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 348 start-page: 880 year: 2015 end-page: 886 article-title: Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin publication-title: Science – volume: 5 start-page: 115 year: 1967 end-page: 121 article-title: The interrelationship of anxiety, hostility and guilt; some physiological correlations publication-title: J Asthma Res – volume: 24 start-page: 1777 year: 2018 end-page: 1789 article-title: Clonal expansion and diversification of cancer‐associated mutations in endometriosis and normal endometrium publication-title: Cell Rep – volume: 70 start-page: 6225 year: 2010 end-page: 6232 article-title: Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer publication-title: Cancer Res – volume: 363 start-page: 1532 year: 2010 end-page: 1543 article-title: ARID1A mutations in endometriosis‐associated ovarian carcinomas publication-title: N Engl J Med – volume: 446 start-page: 153 year: 2007 end-page: 158 article-title: Patterns of somatic mutation in human cancer genomes publication-title: Nature – volume: 13 start-page: 3 year: 2016 end-page: 11 article-title: Current practices and guidelines for clinical next‐generation sequencing oncology testing publication-title: Cancer Biol Med – volume: 14 year: 2018 article-title: Aging and the rise of somatic cancer‐associated mutations in normal tissues publication-title: PLoS Genet – volume: 4 start-page: 149 year: 2018 end-page: 153 article-title: You won't believe this old test … that does cheap single‐cell mutation detection publication-title: J Pathol Clin Res – volume: 12 start-page: 5932 year: 2006 end-page: 5935 article-title: PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia publication-title: Clin Cancer Res – volume: 115 start-page: 2111 year: 2009 end-page: 2118 article-title: Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms publication-title: Cancer – year: 2018 – volume: 14 start-page: 5367 year: 2013 end-page: 5379 article-title: Endometriosis‐associated ovarian cancer: a review of pathogenesis publication-title: Int J Mol Sci – volume: 349 start-page: 1483 year: 2015 end-page: 1489 article-title: Somatic mutation in cancer and normal cells publication-title: Science – volume: 100 start-page: 57 year: 2000 end-page: 70 article-title: The hallmarks of cancer publication-title: Cell – volume: 44 start-page: 651 year: 2012 end-page: 658 article-title: Detectable clonal mosaicism and its relationship to aging and cancer publication-title: Nat Genet – volume: 34 start-page: 69 year: 2019 end-page: 78 article-title: Iatrogenic endometriosis harbors somatic cancer‐driver mutations publication-title: Hum Reprod – volume: 9 start-page: 111 year: 1925 end-page: 114 article-title: Endometrial carcinoma of the ovary arising in endometrial tissue in that organ publication-title: Am J Obstet Gynecol – volume: 5 year: 2010 article-title: Stem cell‐like properties of the endometrial side population: implication in endometrial regeneration publication-title: PLoS One – volume: 53 start-page: 1906 year: 1993 end-page: 1910 article-title: Mutation of the Ki‐ras protooncogene in human endometrial hyperplasia and carcinoma publication-title: Cancer Res – volume: 246 start-page: 257 year: 2018 end-page: 260 article-title: Distinct developmental trajectories of endometriotic epithelium and stroma: implications for the origins of endometriosis publication-title: J Pathol – volume: 2012 start-page: 33 year: 2012 end-page: 47 article-title: The genomics and genetics of endometrial cancer publication-title: Adv Genomics Genet – volume: 10 start-page: 261 year: 2014 end-page: 275 article-title: Endometriosis: pathogenesis and treatment publication-title: Nat Rev Endocrinol – volume: 362 start-page: 911 year: 2018 end-page: 917 article-title: Somatic mutant clones colonize the human esophagus with age publication-title: Science – volume: 497 start-page: 67 year: 2013 end-page: 73 article-title: Integrated genomic characterization of endometrial carcinoma publication-title: Nature – volume: 60 start-page: 7052 year: 2000 end-page: 7056 article-title: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary publication-title: Cancer Res – volume: 378 start-page: 250 year: 2018 end-page: 261 article-title: Somatic activating KRAS mutations in arteriovenous malformations of the brain publication-title: N Engl J Med – volume: 362 start-page: 2389 year: 2010 end-page: 2398 article-title: Clinical practice endometriosis publication-title: N Engl J Med – volume: 376 start-page: 1835 year: 2017 end-page: 1848 article-title: Cancer‐associated mutations in endometriosis without cancer publication-title: N Engl J Med – volume: 236 start-page: 201 year: 2015 end-page: 209 article-title: Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden publication-title: J Pathol – start-page: 505685 year: 2018 article-title: The mutational landscape of normal human endometrial epithelium publication-title: bioRxiv – volume: 4 start-page: 154 year: 2018 end-page: 166 article-title: Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers publication-title: J Pathol Clin Res – volume: 458 start-page: 719 year: 2009 end-page: 724 article-title: The cancer genome publication-title: Nature – volume: 74 start-page: 2796 year: 2014 end-page: 2802 article-title: Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues publication-title: Cancer Res – ident: e_1_2_7_11_1 doi: 10.1073/pnas.1601311113 – ident: e_1_2_7_32_1 doi: 10.1038/nrendo.2013.255 – ident: e_1_2_7_36_1 doi: 10.1016/j.celrep.2018.07.037 – ident: e_1_2_7_21_1 doi: 10.1158/0008-5472.CAN-10-0149 – volume: 53 start-page: 1906 year: 1993 ident: e_1_2_7_13_1 article-title: Mutation of the Ki‐ras protooncogene in human endometrial hyperplasia and carcinoma publication-title: Cancer Res – ident: e_1_2_7_5_1 doi: 10.1038/nature05610 – ident: e_1_2_7_25_1 doi: 10.1002/cjp2.103 – ident: e_1_2_7_6_1 doi: 10.1126/science.aab4082 – ident: e_1_2_7_7_1 doi: 10.20892/j.issn.2095-3941.2016.0004 – ident: e_1_2_7_39_1 doi: 10.3109/02770906709104321 – ident: e_1_2_7_4_1 doi: 10.1038/nature07943 – ident: e_1_2_7_8_1 doi: 10.1371/journal.pgen.1007108 – ident: e_1_2_7_35_1 doi: 10.1002/path.4516 – ident: e_1_2_7_24_1 doi: 10.1002/path.5136 – ident: e_1_2_7_30_1 doi: 10.1016/S0002-9378(25)90949-0 – ident: e_1_2_7_29_1 doi: 10.3390/ijms14035367 – ident: e_1_2_7_22_1 – ident: e_1_2_7_26_1 doi: 10.1002/cjp2.108 – ident: e_1_2_7_10_1 doi: 10.1038/ng.2270 – ident: e_1_2_7_15_1 doi: 10.1158/1078-0432.CCR-06-1375 – ident: e_1_2_7_40_1 doi: 10.1126/scitranslmed.aap8793 – ident: e_1_2_7_18_1 doi: 10.1093/humrep/dey332 – ident: e_1_2_7_14_1 doi: 10.1309/7JX6-B9U9-3P0R-EQNY – ident: e_1_2_7_3_1 doi: 10.1016/j.cell.2011.02.013 – volume: 2012 start-page: 33 year: 2012 ident: e_1_2_7_28_1 article-title: The genomics and genetics of endometrial cancer publication-title: Adv Genomics Genet – ident: e_1_2_7_20_1 doi: 10.1002/cncr.24218 – ident: e_1_2_7_31_1 doi: 10.1056/NEJMcp1000274 – ident: e_1_2_7_17_1 doi: 10.1056/NEJMoa1614814 – ident: e_1_2_7_34_1 doi: 10.1056/NEJMoa1008433 – ident: e_1_2_7_37_1 doi: 10.1101/505685 – ident: e_1_2_7_19_1 doi: 10.1158/0008-5472.CAN-14-0108 – ident: e_1_2_7_23_1 doi: 10.1093/nar/gkw1121 – ident: e_1_2_7_2_1 doi: 10.1016/S0092-8674(00)81683-9 – ident: e_1_2_7_9_1 doi: 10.1126/science.aaa6806 – ident: e_1_2_7_12_1 doi: 10.1126/science.aau3879 – ident: e_1_2_7_16_1 doi: 10.1371/journal.pone.0010387 – ident: e_1_2_7_27_1 doi: 10.1038/nature12113 – volume: 60 start-page: 7052 year: 2000 ident: e_1_2_7_33_1 article-title: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary publication-title: Cancer Res – ident: e_1_2_7_38_1 doi: 10.1056/NEJMoa1709449
SSID	ssj0009955
Score	2.601857
Snippet	The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	173
SubjectTerms	Adult Age Factors Aging Aging - genetics Aging - metabolism digital PCR DNA Mutational Analysis Early Detection of Cancer - methods Endometrial Neoplasms - genetics Endometrial Neoplasms - metabolism Endometrial Neoplasms - pathology Endometriosis Endometrium Endometrium - metabolism Epithelium Esophagus Female Fibroblast growth factor receptor 2 Gynecological cancer Healthy Volunteers Humans Hyperplasia Immunohistochemistry Malignancy Middle Aged Mutation Mutation hot spots Mutation Rate Next-generation sequencing normal tissue Oncogenes Paraffin Peritoneum Predictive Value of Tests PTEN protein Reproducibility of Results Skin somatic mutations Uterus Young Adult
Title	Oncogenic mutations in histologically normal endometrium: the new normal?
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.5314 https://www.ncbi.nlm.nih.gov/pubmed/31187483 https://www.proquest.com/docview/2296988433 https://www.proquest.com/docview/2261966618
Volume	249
WOSCitedRecordID	wos000478363700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1096-9896 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009955 issn: 0022-3417 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fS9xAEB70FPFFq1a9amVbfPAlNdndJLv6INJ6WLBWROXewv6Eg7uceJ7gf9_ZJBeRWij4FthZJuzOzH6T2XwDsB8bxxylSUTz3ERcxTbSPMsiQ4XiwkqlKy69u4v88lL0-_JqDo5n_8LU_BDtB7fgGVW8Dg6u9OTwhTQ0dOz9hhbE52GBot2mHVj4cd27vXjh3JVp2pKF8ySfEQvF9LCd_Po4-gtjvoas1ZnTW33X236AlQZqktPaNtZgzpXrsPSrKaZvwM_fpRmj_QwMGU3rivyEDEpSURA3IXH4TMqAaofElXY8Cu23pqMjgqiRIB5vxk4-wm3v7Ob7edR0VogMT2QohSiR5D5NhIqZY9ZY75jWVpvYIn5URknlcSSz3otcJ57nWiC08AKzOYNBchM65bh020C4jKmyyrOEZdz4FONBjELaOs8YaunCwWyBC9PQjofuF8OiJkymRViaIixNF762ovc118ZbQruzXSoad5sUlMpMCsEZ68KXdhgdJVQ_VOnG0yCDuSIma4nowla9u60WFpquc4GzD6pN_Lf64ur05jw8fPp_0R1YRpgl6yuAu9B5fJi6z7Bonh4Hk4c9mM_7Yq-x3T9ycvHb
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS-QwEB984d0Xn_fY83FR_OCXnm2SbRMRRLxbVm5dRVbZbyXNAxZ2u4frHtx_f5O2WxEVBL8VMmFKMjP5Tab9DcBBqC2zlEYBTRIdcBWaIONxHGgqFBdGqqzg0rvrJN2u6Pfl9RyczP6FKfkh6gs37xlFvPYO7i-kjx5ZQ33L3h9oQnweFjmaEdr34s-b1m3nkXRXNps1WziPkhmzUEiP6slPz6NnIPMpZi0Ondbq-153DVYqsEnOSutYhzmbb8DyZVVO34SLq1yP0YIGmoymZU1-QgY5KUiIq6A4_Edyj2uHxOZmPPINuKajY4K4kSAir8ZOP8Ft61fvvB1UvRUCzSPpiyFKRIlrRkKFzDKjjbMsy0ymQ4MIUmkllcOR2DgnkixyPMkEggsnMJ_TGCY_w0I-zu1XIFyGVBnlWMRirl0TI0KIQpmxjjHU0oDD2QqnuiIe9_0vhmlJmUxTvzSpX5oG7Neif0q2jZeEtmfblFYON0kplbEUgjPWgL16GF3F1z9UbsdTL4PZIqZrkWjAl3J7ay3Mt13nAmcfFrv4uvr0-qzX9g_f3i76HT60e5edtHPR_b0FHxF0yfKDwG1YeLif2h1Y0n8fBpP73cqE_wM2-_Tj
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fS9xAEB70LNIXq1XrtVe7LT74Ek1295JdEUS0h-L1eoiKb2GzP-DgLifeneB_39kkFxErCL4FdpYJuzOz32Q23wDshNoyS2kU0CTRAVehCTIex4GmQnFhpMoKLr2bbtLridtb2V-Aw_m_MCU_RP3BzXtGEa-9g9s74_afWEN9y949NCG-CEvcN5FpwNLpZee6-0S6K9vtmi2cR8mcWSik-_Xk5-fRC5D5HLMWh07n0_tedxVWKrBJjkvrWIMFm3-G5T9VOX0dzv_meowWNNBkNCtr8hMyyElBQlwFxeEjyT2uHRKbm_HIN-CajQ4I4kaCiLwaO9qA687vq5OzoOqtEGgeSV8MUSJKXDsSKmSWGW2cZVlmMh0aRJBKK6kcjsTGOZFkkeNJJhBcOIH5nMYwuQmNfJzbLSBchlQZ5VjEYq5dGyNCiEKZsY4x1NKE3fkKp7oiHvf9L4ZpSZlMU780qV-aJvyqRe9Kto3_CbXm25RWDjdJKZWxFIIz1oSf9TC6iq9_qNyOZ14Gs0VM1yLRhC_l9tZamG-7zgXO3i128XX1af_46sw_fH276A9Y7p920u557-IbfETMJcv7gC1oTO9n9jt80A_TweR-u7Lgf9NN9F4
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncogenic+mutations+in+histologically+normal+endometrium%3A+the+new+normal%3F&rft.jtitle=The+Journal+of+pathology&rft.au=Lac%2C+Vivian&rft.au=Nazeran%2C+Tayyebeh+M&rft.au=Tessier-Cloutier%2C+Basile&rft.au=Aguirre-Hernandez%2C+Rosalia&rft.date=2019-10-01&rft.eissn=1096-9896&rft.volume=249&rft.issue=2&rft.spage=173&rft_id=info:doi/10.1002%2Fpath.5314&rft_id=info%3Apmid%2F31187483&rft.externalDocID=31187483
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon